Qualigen Therapeutics Inc
F:7R9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Qualigen Therapeutics Inc
F:7R9
|
US |
|
E
|
Edenred SE
XBER:QSV
|
FR |
|
Natura & Co Holding SA
BOVESPA:NTCO3
|
BR |
|
Arcelik AS
OTC:ACKAY
|
TR |
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
|
Q
|
QBeyond AG
XHAM:QBY
|
DE |
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
|
Land Securities Group PLC
LSE:LAND
|
UK |
|
R
|
RF Industries Ltd
F:RF5
|
US |
|
Q
|
QBeyond AG
XMUN:QBY0
|
DE |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
US |
|
N
|
NanoViricides Inc
AMEX:NNVC
|
US |
|
Apollo Hospitals Enterprise Ltd
BSE:508869
|
IN |
|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
US |
DCF Value
The DCF Value for
Qualigen Therapeutics Inc (7R9) under the Base Case is hidden
EUR.
Compared with the current market price of 2.625 EUR, the stock appears hidden
.
DCF Model
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more